Internal Medicine, Hematology & Oncology · Murfreesboro, TN
NPI
1811158942
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1840 Medical Center Pkwy, Suite 300
Murfreesboro, TN, 37129
Phone (615) 848-0488
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
122,151 services
Medicare patients, 2024
579
Average age 74
Drug cost, 2024
$5.4M
1,965 prescriptions
Company payments, 2025
$1,847
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeremy S McDuffie was code J9271 (injection, pembrolizumab, 1 mg), 16,200 times for 18 patients. In total Jeremy S McDuffie billed 122,151 services in 157 codes, and Medicare paid $2.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 16,200 | 18 | $43.83 | $710K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 15,000 | 12 | $0.83 | $13K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 10,620 | 11 | $39.09 | $415K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 7,360 | 14 | $2.31 | $17K |
| J0897 Injection, denosumab, 1 mg | Office | 5,220 | 46 | $20.40 | $106K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,100 | 20 | $16.11 | $34K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,977 | 61 | $0.09 | $180 |
| 85025 Blood Count | Office | 1,529 | 393 | $7.50 | $11K |
| 36415 Venipuncture Blood Collection | Office | 1,402 | 413 | $8.54 | $12K |
| 80053 Clinical Chemistry | Office | 1,299 | 404 | $10.26 | $13K |
| 99214 Office E&M - Established | Office | 412 | 213 | $84.23 | $35K |
| 82784 Immunoassay | Office | 384 | 44 | $9.04 | $3,472 |
| 96372 Injection Administration | Office | 314 | 117 | $9.88 | $3,104 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 301 | 169 | $11.93 | $3,590 |
| 96367 Intravenous Infusion, Hydration | Office | 298 | 61 | $19.48 | $5,806 |
By year: 2022 $2.7M for 216,400 services; 2023 $2.4M for 189,121 services; 2024 $2.7M for 122,151 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,529 | 393 | $7.50 | $11K |
| 36415 Venipuncture Blood Collection | 1,402 | 413 | $8.54 | $12K |
| 80053 Clinical Chemistry | 1,299 | 404 | $10.26 | $13K |
| 82784 Immunoassay | 384 | 44 | $9.04 | $3,472 |
| 82728 Clinical Chemistry | 290 | 148 | $13.26 | $3,845 |
| 83540 Clinical Chemistry | 251 | 137 | $6.29 | $1,578 |
| 83550 Clinical Chemistry | 251 | 137 | $8.50 | $2,132 |
| 83521 Immunoassay | 198 | 36 | $16.78 | $3,322 |
| 83615 Clinical Chemistry | 170 | 68 | $5.92 | $1,006 |
| 84443 Clinical Chemistry | 157 | 50 | $16.46 | $2,584 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeremy S McDuffie prescribed most often to Medicare patients was Prednisone, with 122 prescriptions and refills. In total Jeremy S McDuffie wrote 1,965 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 122 | 138 | 28 | $607 |
| Abiraterone Acetate Generic | 104 | 108 | 15 | $199K |
| Acyclovir Generic | 86 | 109 | 14 | $1,208 |
| Anastrozole Generic | 82 | 195 | 21 | $1,757 |
| Gabapentin Generic | 68 | 80 | 15 | $713 |
| Revlimid Lenalidomide | 64 | 64 | 11 | $982K |
| Dexamethasone Generic | 61 | 61 | 17 | $1,135 |
| Xarelto Rivaroxaban | 52 | 101 | 13 | $54K |
| Eliquis Apixaban | 49 | 67 | 16 | $40K |
| Pantoprazole Sodium Generic | 45 | 95 | 16 | $335 |
| Mirtazapine Generic | 43 | 75 | 14 | $1,124 |
| Oxycodone Hcl Generic | 42 | 42 | 12 | $1,324 |
| Ondansetron Odt Ondansetron | 41 | 46 | 25 | $1,036 |
| Nubeqa Darolutamide | 39 | 39 | Under 11 | $504K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 34 | 34 | 24 | $468 |
Brand drugs: 482 claims; generic drugs: 1,483 claims; opioid claims: 136.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremy S McDuffie $1,847 ($1,847 in general payments such as food, travel and fees) from 34 companies. The largest payer was Novartis Pharmaceuticals Corporation with $226.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 9 | $226 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $172 |
| Abbvie Inc. ABBV | 5 | $126 |
| Celgene Corporation BMY | 5 | $121 |
| Eisai Inc. 4523.T | 3 | $88.47 |
| Janssen Biotech, Inc. JNJ | 4 | $82.23 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $76.45 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $75.23 |
| Genzyme Corporation SNY | 2 | $67.55 |
| GlaxoSmithKline, LLC. GSK | 3 | $66.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.